This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study designs and other criteria for inclusion in the review
The authors briefly stated that the systematic review comprised randomised controlled trials.
Sources searched to identify primary studies
Not reported.
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Twenty-one randomized controlled trials were included in the systematic review.
Methods of combining primary studies
Investigation of differences between primary studies
Results of the review
For women having a hysterectomy, GnRHa treatment increased the probability of having the preferred vaginal approach from 12 to 38% (OR 4.7, 95% confidence interval, CI: 3.0 -7.4). For those who underwent an abdominal approach, the probability of a preferred transverse incision increased from 67% without the treatment to 84% with the treatment (OR 2.8, 95% CI: 1.8 -4.3).
Therefore, for patients undergoing hysterectomy:
for the preferred vaginal approach, the final probabilities were 12% without GnRHa treatment versus 38% with treatment; and for those who underwent an abdominal approach, the probability of a preferred transverse incision was 59% without treatment versus 52% with treatment, and for a vertical incision, 29% versus 10%, respectively.
For patients undergoing myomectomy, the final probabilities of the preferred outcome were 67% without GnRHa treatment versus 100% with treatment (OR 8.95, 95% CI: 1.3 -60.1).
The chance of recurrence was 28% for women who did not receive GnRHa therapy and 65% for those receiving GnRHa (OR 4.0, 95% CI: 1.1 -14.7).
Measure of benefits used in the economic analysis
The main benefits considered were the values women placed on avoiding abdominal hysterectomy and on avoiding a vertical incision at either hysterectomy or myomectomy. A willingness-to-pay (WTP) approach was adopted so that the value placed on the preferred surgical outcome could be estimated. 
Direct costs
A WTP survey was conducted on 30 women in New Zealand to determine the value placed on having transverse versus vertical incisions, or vaginal versus abdominal approaches for hysterectomy. The cost/quantity boundary adopted was that of the health care system and the patient. The quantities and the costs were reported separately. Broad expenditure items included GnRHa, consultations in the preoperative phase of the treatment, extra consultations for side effects, theatre costs, length of stay in the hospital, and the cost of consultations in the postoperative phase. The costs of recurrence at two years were considered and discounted at a rate of 6%. Resource consumption was determined from the systematic review and from what constitutes standard practice in New Zealand. The unit costs were obtained from rates charged by the National Womens Hospital, Auckland to private patients and from the market for GnRHa. The price year was 2001.
Statistical analysis of costs
Resource use and the costs were treated deterministically.
Indirect Costs
The indirect costs were represented in time off work (hourly wage rate). The price year was 2001. The estimates were derived using the average hourly rate for women in New Zealand.
Currency
New Zealand dollars (NS$).
Sensitivity analysis
Variability in the data was explored. To examine the sensitivity of the results to the assumptions about the cost and effectiveness, two scenarios were developed. The first was a "worse-case" scenario in which the actual costs were assumed to be 50% greater and the effectiveness 50% worse. The second was a more favourable scenario in which the actual costs were assumed to be 50% less and the effectiveness twice as great.
Estimated benefits used in the economic analysis
For a woman having a hysterectomy, the average WTP for undergoing a vaginal approach rather than an abdominal approach was NZ$644 (range: 200 -2,000), and the WTP for a transverse instead of a vertical approach was NZ$594 (range: 200 -2,000).
For a woman undergoing myomectomy, the WTP was NZ$792 (range: 200 -2,000) for a transverse incision and NZ$25 when a hysterectomy may be needed in the future.
Cost results
The expected cost of preoperative treatment was NZ$4,222 (3,032 without treatment) for a patient undergoing hysterectomy and NZ$5,099 (3,564 without treatment) for a patient undergoing myomectomy.
For both treatments, the preoperative cost was a third of the total (NZ$1,544).
The additional cost of treatment with GnRHa was NZ$1,190 for hysterectomy and NZ$1,535 for myomectomy.
Synthesis of costs and benefits
For hysterectomy, the cost of avoiding one abdominal procedure was NZ$4,577 per case and the cost of avoiding one vertical incision was NZ$6,263.
For myomectomy, the cost of avoiding one vertical incision was NZ$4,651. For a woman having a hysterectomy, the average WTP for having a vaginal approach rather than an abdominal approach was NZ$644. For a woman who may need a hysterectomy in the future, the average WTP for a myomectomy was NZ$25. In both cases the benefits were outweighed by the expected costs.
